Skip navigation

MAD MONEY FEATURES

Podcasts PODCASTS
Watch the Lightning Round whenever and wherever you want.




Widget OFFICIAL MAD MONEY WIDGET
Grab this all-in-one application and get recaps of the show sent right to your desktop or blog.




Soundboard CRAMER'S SOUNDBOARD
Admit it: You’ve always wanted to hit the “They know nothing!” button. Here’s your chance.




Mad Money PhotosCRAMER QUICK PICS
Check out the Mad Money host on set, back to school, behind the scenes and more.




Mad Money VideosVIDEOS
Get all your favorite Cramer clips right here.





ShopSHOP FOR MAD MERCHANDISE
Buy Cramer books, bobbleheads and other Mad Money merchandise.




Ringtones RING TONES
Pick up the phone! It’s Cramer! New Mad Money sounds for your cell phone.




Mobile AlertTEXT MESSAGE ALERT
Mad Money’s mobile. Get show highlights sent to your phone.




Text Size

Cramer last week offered up his prediction of potential winners from the new Medicare bill -- the one that passed in the Senate yesterday. (President Bush has said he'll veto -- but it already passed by a veto-proof margin.) The good news is that Fresenius Med [FMS  Loading...      ()   ], Cramer's fave of the bill, got bumped to a 52-week high today with three points. But what about the losers of the Medicare bill -- the new offenders headed for the Sell Block?



The bill is worth $12.5B and Cramer told you where that money was going -- but where is it coming from? Largely from a 2% cut to HMOs that sell Medicare Advantage plans -- and also doing away with double payments to teaching hospitals.

These HMOs get about 13% in government subsidy for each plan, so 2% may not sound like a big cut at first. The problem is what this bill and what this cut signifies: HMOs have lost the political protection of Republicans as the "Bolsheviks," as Cramer calls Democrats now in control of Congress -- and perhaps the White House in November.

So despite this week's advice from the Cramerican Marine Field Guide to Recession, Cramer advises you "stay the heck away" from Medicare managed HMOs. For example, Healthspring [HS  Loading...      ()   ] gets 88% of its earnings from Medicare Advantage plans -- send that one straight to Gitmo, says Cramer, because that percentage is way too high. Humana [HUM  Loading...      ()   ], another HMO, gets 80% from those plans -- they're getting "waterboarded" too. Coventry [HNT  Loading...      ()   ] gets 32%, lock it up. Healthnet [  Loading...      ()   ]gets 28% -- busted. Triple-S [GTS  Loading...      ()   ] gets 22% -- it's headed for solitary confinement with the rest. UnitedHealth [UNH  Loading...      ()   ] gets only 12% from the plans, but it's going down too. "There's no Eight Amendment in Cramerica." Sorry guys.

These HMOs are what companies offer employees for health plans. So the fewer the employees, the fewer people there are paying their premiums. Unemployment hurts HMOs. Between 2000 and 2002, when unemployment grew monthly by double digits, overall levels of membership at managed care companies fell an average of 1.3% a year. And in the employment boom between 2004 and 2006, HMO membership levels increased an average of 3% per year. But "that party is definitely over," says Cramer.

Bottom line: the tide of both legislation and unemployment is now going against HMOs and they don't stand a chance -- something Jim's been foretelling for months. So it's time to put these "recidivists" in lockdown: Healthspring, Humana, Coventry, Healthnet, Triple-S, UNH. It's the Sell Block for the lot of them.



Questions for Cramer?

Questions, comments, suggestions for the Mad Money website?

© 2008 CNBC, Inc. All Rights Reserved

Permalink: /id/25630777

HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC MOBILE  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis